N6,5'-disubstituted adenosine derivatives as partial agonists for the human adenosine A3 receptor

Journal of Medicinal Chemistry

Volumn 42, Issue 8, 1999, Pages 1393-1400

  Van Tilburg, Erica W ^a   Von Frijtag Drabbe Künzel, Jacobien ^a   De Groote, Miriam ^a   Vollinga, Roel C ^a   Lorenzen, Anna ^b   IJzerman, Ad P ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5' DEOXY 6 N (3 IODOBENZYL) 5' METHYLTHIOADENOSINE; 6 N (3 IODOBENZYL)ADENOSINE; 6 N BENZYL 5' DEOXY 5' METHYLTHIOADENOSINE; 6 N BENZYLADENOSINE; ADENOSINE A3 RECEPTOR; ADENOSINE DERIVATIVE; ADENOSINE RECEPTOR STIMULATING AGENT; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); LUF 5403; LUF 5411; RECEPTOR SUBTYPE; SULFUR 35; UNCLASSIFIED DRUG; ADENOSINE; ADENOSINE RECEPTOR; CYCLIC AMP; DRUG DERIVATIVE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN CORTEX; CHO CELL; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; LIGAND BINDING; NONHUMAN; RAT; ANIMAL; BIOSYNTHESIS; CELL LINE; CHEMISTRY; CORPUS STRIATUM; DRUG POTENTIATION; HAMSTER; IN VITRO STUDY; METABOLISM; RADIOASSAY; SYNTHESIS;

ADENOSINE; ANIMALS; CELL LINE; CEREBRAL CORTEX; CHO CELLS; CORPUS STRIATUM; CRICETINAE; CYCLIC AMP; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; RADIOLIGAND ASSAY; RATS; RECEPTOR, ADENOSINE A3; RECEPTORS, PURINERGIC P1;

EID: 0033594252     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm981090+     Document Type: Article

References (37)

1. Von Lubitz, D. K. J. E. Adenosine and acute treatment of cerebral ischemia and stroke - "put out more flags". In Purinergic approaches in experimental therapeutics; Jacobson, K. A., Jarvis, M. F., Eds.; Wiley-Liss, Inc.: New York, 1997; pp 449-470.
2. 3 adenosine receptor. Mol. Pharmacol. 1994, 45, 1101-1111.
3. Liu, G.-S.; Downey, J. M.; Cohen, M. V., Adenosine, ischemia and preconditioning. In Purinergic approaches in experimental therapeutics; Jacobson, K. A., Jarvis, M. F., Eds.; Wiley-Liss, Inc.: New York, 1997; pp 153-172.
4. 3-adenosine receptors: design of selective ligands and therapeutic prospects. Drugs Future 1995, 20, 689-699.
5. Jacobson, K. A.; Von Lubitz, D. K. J. E.; Daly, J. W.; Fredholm, B. B. Adenosine receptor ligands: differences with acute versus chronic treatment. TiPS 1996, 17, 108-113.
6. Jacobson, M. A.; Bai, T. R. The role of adenosine in asthma. In Purinergic approaches in experimental therapeutics; Jacobson, K. A., Jarvis, M. F., Eds.; Wiley-Liss, Inc.: New York, 1997; pp 315-331.
7. IJzerman, A. P.; Van der Wenden, E. M.; von Frijtag Drabbe Künzel, J. K.; Mathôt, R. A. A.; Danhof, M.; Borea, P. A.; Varani, K. Partial agonism of theophylline-7-riboside on adenosine receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 1994, 350, 638-645.
8. 3-selective adenosine agonists. J. Med. Chem. 1994, 37, 636-646.
9. 3 selective ligands containing bioisosteric isoxazoles. Bioorg. Med. Chem. Lett. 1998, 8, 1767-1770.
10. 3 adenosine receptor agonists. J. Med. Chem. 1998, 41, 3174-3185.
11. 1 receptor. J. Med. Chem. 1998, 41, 102-108.
12. 35S]thio)triphosphate binding. Mol. Pharmacol. 1993, 44, 115-123.
13. 1 adenosine receptor with receptor/G protein complexes in rat brain membranes. Mol. Pharmacol. 1996, 49, 915-926.
14. 6-(nitro-and-aminobenzyl)-adenosines. J. Med. Chem. 1975, 18 (8), 780-783.
15. 3 adenosine receptors. J. Med. Chem. 1994, 37, 3614-3621.
16. Borchardt, R. T.; Huber, J. A.; Wu, Y. S. A convenient preparation of S-adenosylhomocysteine and related compounds. J. Org. Chem. 1976, 41 (3), 565-567.
17. 3H] NECA in rat striatal membranes. Mol. Pharmacol. 1986, 29, 331-346.
18. Brown, D. M.; Cochran, W.; Medlin, E. H. and Varadarajan, S. 5′-Deoxy-5-iodo-cyclouridine: an X-ray crystallographic study. J. Chem. Soc. 1956, 4873-4876.
19. 2:5′-cyclouridine and a synthesis of isocytine. J. Chem. Soc. 1957, 868-872.
20. Jahn, W. Synthese 5′-substituierte Adenosinderivate. Chem. Ber. 1965, 98, 1705-1708.
21. Srivastava, P. C.; Robins, R. K.;d Meyer, R. B. J. Synthesis and properties of purine nucleosides and nucleotides. In Chemistry of nucleosides and nucleotides; Townsend, L. B., Ed.; Plenum Press: New York, 1988; pp 113-282.
22. Dods, R. F.; Roth, J. S. Halogenation of nucleosides by (halomethylene) dimethylene ammonium halides. Tetrahedron Lett. 1969, 165-168.
23. Kikugawa, K.; Ichino, M. On the reaction of Vilsmeier - Haack reagent with nucleoside: a convenient synthesis of 2,2′-cyclocytidine. Tetrahedron Lett. 1970, 867-870.
24. Kikugawa, K.; Ichino, M. Direct halogenation of sugar moiety of nucleosides. Tetrahedron Lett. 1971, 87-90.
25. Robins, M. J.; Hansske, F.; Wnuk, S. F.; Kanai, T. Nucleic acid related compounds. 66. Improved synthesis of 5′-chloro-5′-deoxyand 5′-S-aryl (or alkyl)-5′-thionucleosides. Can. J. Chem. 1992, 69, 1468-1474.
26. Jacobson, K. A.; van Galen, P. J. M.; Williams, M. Adenosine receptors: pharmacology, structure - activity relationships, and therapeutic potential. J. Med. Chem. 1992, 35, 407-422.
27. 3 adenosine receptors. J. Med. Chem. 1996, 39, 802-806.
28. 3 adenosine receptor. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 7432-7436.
29. 2-adenosine receptors coupled to adenylate cyclase. Biochem. Pharmacol. 1992, 43, 1089-1093.
30. Taylor, M. D.; Moos, W. H.; Hamilton, H. W.; Szotek, D. S.; Patt, W. C.; Badger, E. W.; Bristol, J. A.; Bruns, R. F.; Heffner, T. G.; Mertz, T. E. Ribose-modified adenosine analogues as adenosine receptor agonists. J. Med. Chem. 1986, 29, 346-353.
31. Bruns, R. F. Adenosine receptor activation in human fibroblasts: nucleoside agonist and antagonists. Can. J. Physiol. Pharmacol. 1980, 673-691.
32. 3 adenosine receptors: Structure - activity relationships of 1,3-dialkylxanthine 7-riboside derivatives. J. Med. Chem. 1994, 37, 4020-4030.
33. 3 adenosine receptor-selective antagonists. Neuropharmacology 1997, 36, 1157-1165.
34. 6-(ω-aminoalkyl)-adenosines on adenosine receptor affinity and intrinsic activity. Eur. J. Pharmacol. 1989, 172, 185-193.
35. 2 receptors in rat brain. J. Pharmacol. Exp. Ther. 1989, 251, 888-893.
36. 3 adenosine receptor. Mol. Pharmacol. 1994, 45, 978-982.
37. 1 receptor. Eur. J. Pharmacol-Mol. Pharmacol. Sect. 1995, 290, 189-199.